What is Climb Bio, Inc.'s sales milestones — milestone payments?

Climb Bio, Inc. (CLYM) reported sales milestones — milestone payments of $8M in Q1 2026.

What does sales milestones — milestone payments mean?

This metric represents the revenue recognized from contingent payments triggered by the achievement of specific commercial sales thresholds for licensed therapeutic products. It reflects the successful market penetration and commercial performance of the company's drug candidates as they reach pre-defined sales targets under partnership or licensing agreements. These payments serve as a key indicator of the commercial viability and market adoption of the company's clinical-stage pipeline assets.

Climb Bio, Inc. CLYM Sales Milestones — Milestone Payments

Similar metrics at other companies

TARSCommercial Sales Milestone Payments — Contractual milestone payment net sales

$102M0.0%

TARSCommercial and Sales Milestones — Maximum milestone payments

$77M0.0%

TARSCommercial Sales Milestone Payments — Maximum milestone payments

$92M—

TARSDevelopment and Regulatory Milestone — Milestone payments to be achieved

$67.5M0.0%

INSMPayment Of Milestone

$15M—

AMP

AMPHSales Milestone Payments — Asset Acquisition Contingent Consideration Threshold Cumulative Sales Milestone

$75M—

Other financials

Income statement

See full

Operating income-$15.2M+33.9%

Net income-$13.7M+34.0%

EPS (diluted)-$0.20+35.5%

Balance sheet

See full

Cash & equivalents$8.4M-71.2%

Total debt$479.0K+1.1%

Total equity$148.1M-23.4%

Total assets$152.4M-24.1%

Cash flow

See full

Operating cash flow-$14.4M+6.8%

CapEx$109.0K—

Free cash flow-$15.6M-183%

Valuation

See full

Market cap$724.95M+787%

Enterprise value$717.07M+1,247%

Returns & leverage

See full

Return on equity-30.9%-10.3pp

Debt / equity0×0.0×

Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept clym:MilestonePayments.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s sales milestones — milestone payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Climb Bio, Inc.'s sales milestones — milestone payments?: Climb Bio, Inc. (CLYM) reported sales milestones — milestone payments of $8M in Q1 2026.
What does sales milestones — milestone payments mean?: This metric represents the revenue recognized from contingent payments triggered by the achievement of specific commercial sales thresholds for licensed therapeutic products. It reflects the successful market penetration and commercial performance of the company's drug candidates as they reach pre-defined sales targets under partnership or licensing agreements. These payments serve as a key indicator of the commercial viability and market adoption of the company's clinical-stage pipeline assets.